Actively Recruiting

Phase Not Applicable
Age: 12Years - 20Years
All Genders
Healthy Volunteers
NCT05477134

Arginine Metabolism in Youth With Type 2 Diabetes

Led by Baylor College of Medicine · Updated on 2026-01-27

30

Participants Needed

1

Research Sites

238 weeks

Total Duration

On this page

Sponsors

B

Baylor College of Medicine

Lead Sponsor

N

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Type 2 diabetes (T2D), once considered only "a disease of older ages," is now a significant public health concern in youth. Although it is characterized by insulin resistance and impaired insulin secretion, its precise etiology and pathogenesis are not yet fully understood. This study aims to (1) explore arginine metabolism in youth with T2D via safe, minimally invasive kinetic experiments using stable isotope tracers and targeted metabolomics, and (2) determine the effect of exogenous arginine administration on β-cell function in youth with T2D, potentially supporting the use of this safe, low-cost, and readily available nutrient to improve pediatric diabetes outcomes.

CONDITIONS

Official Title

Arginine Metabolism in Youth With Type 2 Diabetes

Who Can Participate

Age: 12Years - 20Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Youth with type 2 diabetes and healthy controls meeting the study's other criteria
  • Girls aged 12 to 20 years who have started menstruating (postmenarchal)
  • Boys aged 14 to 20 years who are at Tanner stage 5 genital development
  • Youth with type 2 diabetes must have a diagnosis and diabetes duration between 3 months and 10 years
Not Eligible

You will not qualify if you...

  • Previous history of diabetic ketoacidosis (DKA)
  • Poorly controlled diabetes with HbA1c greater than 7.5%
  • Abnormal liver, thyroid, gonadal, or adrenal function
  • Renal insufficiency with eGFR less than 90 mL/min/1.73 m2
  • Use of glucose-lowering medications other than metformin, insulin, and liraglutide
  • Use of any medication likely to interfere with amino acid metabolism
  • Use of any hormonal replacement therapy
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Texas Children's Hospital / Baylor College of Medicine

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

M

Mustafa Tosur, MD

CONTACT

L

Lori Malone

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here